200 related articles for article (PubMed ID: 8043520)
21. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
[TBL] [Abstract][Full Text] [Related]
22. Overexpressed androgen receptor linked to p21WAF1 silencing may be responsible for androgen independence and resistance to apoptosis of a prostate cancer cell line.
Wang LG; Ossowski L; Ferrari AC
Cancer Res; 2001 Oct; 61(20):7544-51. PubMed ID: 11606392
[TBL] [Abstract][Full Text] [Related]
23. Epigallocatechin-3-gallate and bicalutamide cause growth arrest and apoptosis in NRP-152 and NRP-154 prostate epithelial cells.
Morrissey C; Brown M; O'Sullivan J; Weathered N; Watson RW; Tenniswood M
Int J Urol; 2007 Jun; 14(6):545-51. PubMed ID: 17593102
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal analysis of androgen deprivation of prostate cancer cells identifies pathways to androgen independence.
D'Antonio JM; Ma C; Monzon FA; Pflug BR
Prostate; 2008 May; 68(7):698-714. PubMed ID: 18302219
[TBL] [Abstract][Full Text] [Related]
25. Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1.
Amler LC; Agus DB; LeDuc C; Sapinoso ML; Fox WD; Kern S; Lee D; Wang V; Leysens M; Higgins B; Martin J; Gerald W; Dracopoli N; Cordon-Cardo C; Scher HI; Hampton GM
Cancer Res; 2000 Nov; 60(21):6134-41. PubMed ID: 11085537
[TBL] [Abstract][Full Text] [Related]
26. An elevated bax/bcl-2 ratio corresponds with the onset of prostate epithelial cell apoptosis.
Perlman H; Zhang X; Chen MW; Walsh K; Buttyan R
Cell Death Differ; 1999 Jan; 6(1):48-54. PubMed ID: 10200547
[TBL] [Abstract][Full Text] [Related]
27. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
[TBL] [Abstract][Full Text] [Related]
28. Guanosine phosphate binding protein coupled receptors in prostate cancer: a review.
Raj GV; Barki-Harrington L; Kue PF; Daaka Y
J Urol; 2002 Mar; 167(3):1458-63. PubMed ID: 11832770
[TBL] [Abstract][Full Text] [Related]
29. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
[TBL] [Abstract][Full Text] [Related]
30. Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells.
Hsieh CL; Cai C; Giwa A; Bivins A; Chen SY; Sabry D; Govardhan K; Shemshedini L
J Mol Endocrinol; 2008 Jul; 41(1):13-23. PubMed ID: 18469090
[TBL] [Abstract][Full Text] [Related]
31. Androgen blocks apoptosis of hormone-dependent prostate cancer cells.
Kimura K; Markowski M; Bowen C; Gelmann EP
Cancer Res; 2001 Jul; 61(14):5611-8. PubMed ID: 11454715
[TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of PLZF as a prostatic androgen-responsive gene.
Jiang F; Wang Z
Prostate; 2004 Jun; 59(4):426-35. PubMed ID: 15065091
[TBL] [Abstract][Full Text] [Related]
33. Androgen regulation of programmed death of normal and malignant prostatic cells.
Isaacs JT; Lundmo PI; Berges R; Martikainen P; Kyprianou N; English HF
J Androl; 1992; 13(6):457-64. PubMed ID: 1293127
[TBL] [Abstract][Full Text] [Related]
34. Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent.
Asamoto M; Hokaiwado N; Cho YM; Takahashi S; Ikeda Y; Imaida K; Shirai T
Cancer Res; 2001 Jun; 61(12):4693-700. PubMed ID: 11406539
[TBL] [Abstract][Full Text] [Related]
35. Does the lack of regression-associated mRNA expression render a rat ventral prostate epithelial cell line androgen independent?
Montpetit ML; Tenniswood MP
J Cell Biochem; 1989 Mar; 39(3):285-92. PubMed ID: 2708460
[TBL] [Abstract][Full Text] [Related]
36. Differential gene regulation during programmed death (apoptosis) versus proliferation of prostatic glandular cells induced by androgen manipulation.
Furuya Y; Isaacs JT
Endocrinology; 1993 Dec; 133(6):2660-6. PubMed ID: 8243289
[TBL] [Abstract][Full Text] [Related]
37. Differential androgen regulation of rat prostatic acid phosphatase transcripts.
Porvari K; Kurkela R; Kivinen A; Vihko P
Biochem Biophys Res Commun; 1995 Aug; 213(3):861-8. PubMed ID: 7654248
[TBL] [Abstract][Full Text] [Related]
38. Programmed death of nonproliferating androgen-independent prostatic cancer cells.
Martikainen P; Kyprianou N; Tucker RW; Isaacs JT
Cancer Res; 1991 Sep; 51(17):4693-700. PubMed ID: 1873814
[TBL] [Abstract][Full Text] [Related]
39. Androgen suppressed apoptosis is modified in p53 deficient mice.
Colombel M; Radvanyi F; Blanche M; Abbou C; Buttyan R; Donehower LA; Chopin D; Thiery JP
Oncogene; 1995 Apr; 10(7):1269-74. PubMed ID: 7731676
[TBL] [Abstract][Full Text] [Related]
40. Castration-induced apoptotic cell death in the Brown Norway rat prostate decreases as a function of age.
Banerjee S; Banerjee PP; Brown TR
Endocrinology; 2000 Feb; 141(2):821-32. PubMed ID: 10650965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
